Madrigal Pharmaceuticals (MDGL) 10-K2021 FY Annual report

Filed: 24 Feb 22, 1:39pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: add, adult, alex, ANDA, ballot, Becky, Cadila, California, CAP, CCPA, CI, cirrhotic, cohort, column, commitment, concealing, confidence, confirmatory, cooperate, Cooperation, coordinated, CPPA, CPRA, CRL, CTCAE, deadline, dedicated, disagree, double, DSMB, expend, factual, faster, fibroscan, fifty, fraudulent, GDPR, half, harmonized, height, Hepion, HIPAA, histopathological, howarth, imaging, implicate, imprisonment, improperly, injunctive, intentionally, intermediate, interval, IV, Justice, Kingdom, LDLc, left, legitimize, liable, mid, misrepresenting, missed, MRE, mutual, Nausea, NCE, NCI, nineteen, North, NorthSea, Notwithstanding, OL, OLE, organizational, outlined, overcharging, overcome, overhaul, owner, Paragraph, PDUFA, preclude, precluded, presence, proactive, qui, recall, relief, repeal, rescinded, resident, resubmission, RLD, rolling, SE, seizure, seventy, Shield, society, standpoint, stay, stool, strict, sued, Switzerland, tam, TE, TEAE, throughwhich, transmit, transparency, Treaty, unavailable, unforeseen, unsettled, visit, volume, waiting, whichever

Removed: administer, Affordability, amendment, American, August, automatically, broadest, closed, concluding, concurrently, consummation, contemplated, diagnostic, Education, effected, enactment, encouraged, ethically, expedited, flexible, formed, Genfit, Goldman, Hepatology, IMM, inherently, Integrated, irreversible, line, manuscript, marc, merged, methodology, morbidity, mortality, originally, output, progressing, promulgate, promulgation, rapid, rarity, Rebate, Reconciliation, representing, retrospectively, schneebaum, split, strongest, subsidiary, summarizing, surviving, threshold, toxic, treating, underwriting, underwritten, vertical, Vice, workshop

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

MDGL similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-256666, 333-219304) and Form S-8 (Nos. 333-141903, 333-152824, 333-173862, 333-181117, 333-187243, 333-194477, 333-202680, 333-206128, 333-212615, 333-224503, 333-249866 and 333-257506) of Madrigal Pharmaceuticals, Inc. of our report dated February 24, 2022 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

February 24, 2022